Benjamin R. Davies - 02 Nov 2026 Form 4 Insider Report for NORTHROP GRUMMAN CORP /DE/ (NOC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Nov 2026, 16:18:04 UTC
Prior SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jennifer C. McGarey, Attorney-in-Fact
Filing notes and source

Key filing fact

Benjamin R. Davies filed Form 4 for NORTHROP GRUMMAN CORP /DE/ (NOC) on 04 Nov 2026.

Key facts

  • This page summarizes Benjamin R. Davies's Form 4 filing for NORTHROP GRUMMAN CORP /DE/ (NOC).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Nov 2026, 16:18.

Change

  • Previous filing in this sequence was filed on 19 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002026085 Primary reporting owner

Davies Benjamin R.

Relationship
CVP & Pres. Defense Systems
Address
2980 FAIRVIEW PARK DRIVE, FALLS CHURCH
Signature
/s/ Jennifer C. McGarey, Attorney-in-Fact
Signature date
04 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+641
Change %
+425%
Price
$0.000000*
Shares after
792
Date
02 Nov 2026
Ownership
Direct
NOC transaction

Common Stock

Tax liability

Transaction value
Shares
-281
Change %
-35%
Price
$555.32*
Shares after
511
Date
02 Nov 2026
Ownership
Direct
NOC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
02 Nov 2026
Ownership
Held in Northrop Grumman Savings Plan
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NOC transaction Derivative

Restricted Stock Rights

Options Exercise

Transaction value
Shares
-641
Change %
-9.9%
Price
$0.000000*
Shares after
5,803
Date
02 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
641
Exercise price
Footnotes
F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Held in the Northrop Grumman Savings Plan (the "Plan"), a qualified defined contribution plan, as of November 2, 2026. Share totals with respect to the Plan are based upon unit accounting and therefore may reflect a change in units attributable to an individual though no acquisition or disposition occurred.

Footnote F2

Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.

Footnote F3

Shares issued upon vesting of RSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 11/1/23 that vested on 11/2/26.

Footnote F4

Total amount includes (i) 1,008 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (ii) 638 RSRs granted under the 2011 LTISP on 7/31/24 that will vest on 8/2/27 ; (iii) 2,456 RSRs granted under the 2024 Long-Term Incentive Stock Plan ("2024 LTISP") on 2/18/25 that will vest on 2/18/28; and (iv) 1,701 RSRs granted under the 2024 LTISP on 2/11/26 that will vest on 2/12/29.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .